Entity family
Clinical therapies and care approaches used to manage a condition. Examples include immunotherapy, radiotherapy, rehabilitation.
This treatment is selected. Its supporting articles are shown below.
…o address these limitations, this study aims to develop a novel CAR-T therapy strategy, which knocks out intracellular immune checkpoint CISH…
…findings support the clinical development of PD-L1-EphA2 tandem CAR-T therapy for treating solid tumors expressing either or both antigens, a…
…ic CARs (Chimeric Antigen Receptors) to target cancerous cells. CAR-T therapy is largely limited to blood-based cancers, most commonly leukem…
…Background CAR T-cell therapy has achieved remarkable responses in patients with relapsed/ref…
…Background CAR-T therapy is an effective immunotherapy for hematologic malignancies. How…
…Background Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionised the treatment of haematological malignancies…
…hs in the U.S., with rising incidence among young adults. While CAR-T cell therapy has been successful in treating some hematologic malignancies, …
…Background CAR-T therapy has demonstrated curative potential against hematological malig…
…Background CAR-T therapy has demonstrated potent anti-tumor efficacy in treating a range…
…s in treating relapsed/refractory hematologic malignancies, and CAR-T cell therapy is being avidly pursued for treatment of solid tumors. However,…
…sociated cognitive impairment is common in patients who receive chimeric antigen receptor T-cell (CAR-T) therapy. Hence, monitoring cognitive function is vital to guide treatme…